HOME >> BIOLOGY >> NEWS
Mouse mimics chronic leukemia, will aid drug development

COLUMBUS , Ohio -- A study by cancer researchers here reveals that a new strain of mice offers the first real animal model for an incurable form of chronic leukemia and should greatly aid the development of new drugs for the disease.

The mouse, called the TCL-1 transgenic mouse, develops a malignancy that closely mimics chronic lymphocytic leukemia (CLL). The lack of an animal model has greatly hampered the development of new treatments for CLL as well as research into its causes and the changes that drive drug resistance.

"This mouse strain shares many of the molecular and genetic features of human CLL, responds to drugs typically used to treat the disease and develops drug resistance that renders treatment ineffective, as often happens in CLL patients," says principal investigator John C. Byrd, professor of internal medicine.

Byrd is a specialist in CLL at the Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James).

"The strain should be extremely valuable for the development and testing of both conventional drugs and those aimed at molecular targets for CLL."

The findings are published in the Aug. 15 issue of the journal Blood, which includes a commentary about the significance of the research.

An estimated 10,000 Americans will develop CLL in 2006, and about 4,600 will die of the disease. The malignancy usually strikes people aged 50 or older and causes the proliferation of white blood cells called lymphocytes. Other effects include severe anemia and a high risk of viral, bacterial and fungal infections. Average survival after diagnosis is eight to 12 years. The standard treatment for CLL is the drug fludarabine, but the disease often becomes resistant to the drug.

This TCL-1 mouse strain was originally developed by OSU cancer researcher Carlo M. Croce, professor and chair, department of molecular viro
'"/>

Contact: Darrell E. Ward
Darrell.Ward@osumc.edu
614-293-3737
Ohio State University
22-Aug-2006


Page: 1 2

Related biology news :

1. Mouse model advances understanding of synovial sarcoma
2. Mouse FH knockout resembles human renal cell cancer
3. Mouse stem cell line advance suggests potential for IVF-incompetent eggs
4. Mouse model underestimates the critical role of Tyk2 in human immune system
5. Mouse DNA to aid biomedical research
6. Mouse strain with gene stutter will help leukemia research
7. Knockout Mouse Project
8. NIH launches Knockout Mouse Project
9. Mouse, frog and bird put Snail and Slug to different uses
10. Mouse study reveals human X-SCID gene therapy poses substantial cancer risk
11. Mouse to man: The story of chromosomes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/29/2018)... ... August 28, 2018 , ... ... unlocking the full power of positron emission tomography (PET), today launched its ... Dx is helping clinicians and researchers study and cure debilitating diseases, earlier, ...
(Date:8/26/2018)... ... August 24, 2018 , ... ... clinical diagnostic laboratories. However, this technology introduces many well-described challenges around data ... leads the South London NHS Genomic Medicine Centre. The Viapath Genetics Laboratories ...
(Date:8/23/2018)... Calif. (PRWEB) , ... August 21, 2018 , ... ... engineer the genomes of diverse cell types and species for the robust functional ... research tool for the development of T-cell based immunotherapies, the study of the ...
Breaking Biology News(10 mins):
(Date:8/17/2018)... ... August 16, 2018 , ... KCAS Bioanalytical and Biomarker ... expansion of their team. Dr. Dawn Dufield, Ph.D., joins KCAS as Director of ... LC-MS/MS group that will specialize in developing quantitative LC-MS/MS assays for biopharma molecules. ...
(Date:8/17/2018)... ... August 17, 2018 , ... ... and Environmental Repositories (ISBER) is pleased to announce the release of the Russian ... publication, originally released in January 2018, is a practice-changing publication aimed at advancing ...
(Date:8/14/2018)... ... August 14, 2018 , ... ... treating opioid use disorder. BUP is often prescribed as a sublingual co-formulation with ... , In this webinar, participants will learn from a review of the pharmacokinetics ...
(Date:8/11/2018)... ... August 10, 2018 , ... Researchers performing pressurized NMR or EPR experiments face ... Protection Chamber for High-Pressure NMR & EPR by Wilmad-LabGlass – SP Scienceware shields ... , High-pressure experiments have significantly grown in popularity over the last several years. ...
Breaking Biology Technology:
Cached News: